Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Weiss, Roger
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Roger Douglas Weiss, M.D.
Title
Professor of Psychiatry
Institution
McLean Hospital
Department
Psychiatry
Address
Mclean Hospital
Psychiatry
115 Mill St
Belmont MA 02478
Phone
617/855-2242
Fax
617/855-2699
vCard
Download vCard
(
login for email
)
research activities and funding
|
selected publications
|
Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can
login
to make corrections and additions.
Most Recent
|
List All
R21DA041682
(CHAN, KEVIN E)
Mar 15, 2017 - Feb 28, 2019
NIH
Opioid Use and Abuse in the Dialysis Population
Role: Co-Principal Investigator
K24DA022288
(WEISS, ROGER D.)
Apr 1, 2007 - Mar 1, 2019
NIH
Mentoring in drug abuse and dual diagnosis research
Role: Principal Investigator
UG1DA015831
(D'ONOFRIO, GAIL)
Sep 30, 2002 - Feb 28, 2025
NIH
The National Drug Abuse Clinical Trials Network: New England Consortium Node
Role: Co-Principal Investigator
U10DA015831
(WEISS, ROGER D.)
Sep 30, 2002 - Aug 31, 2015
NIH
The National Drug Abuse Treatment Clinical Trials Network (U10)
Role: Co-Principal Investigator
R01DA015968
(WEISS, ROGER D.)
Sep 30, 2002 - Jan 31, 2009
NIH
Modifying Group Therapy for Bipolar Abusers
Role: Principal Investigator
U10AA011756
(WEISS, ROGER D.)
Sep 30, 1997 - Aug 31, 2007
NIH
Behavioral and Pharmacologic Treatment of Alcoholism
Role: Principal Investigator
K02DA000326
(WEISS, ROGER D.)
Apr 20, 1997 - Mar 31, 2007
NIH
Treatment of Drug Dependence and Psychiatric Illness
Role: Principal Investigator
R01DA009400
(WEISS, ROGER D.)
Sep 30, 1994 - Dec 31, 2003
NIH
RELAPSE PREVENTION GROUP FOR BIPOLAR SUBSTANCE ABUSERS
Role: Principal Investigator
U01DA007693
(WEISS, ROGER D.)
Sep 30, 1991 - Jul 31, 2000
NIH
PSYCHOSOCIAL TREATMENT OF COCAINE USE DISORDER
Role: Principal Investigator
U18DA007693
(WEISS, ROGER D.)
Sep 30, 1991 - Aug 31, 1995
NIH
PSYCHOSOCIAL TREATMENT OF COCAINE USE DISORDER
Role: Principal Investigator
R29DA005944
(WEISS, ROGER D.)
Aug 1, 1989 - Jul 31, 1995
NIH
PREDICTORS OF OUTCOME IN COCAINE DEPENDENCE
Role: Principal Investigator
S07RR005484
(COLE, JONATHAN O)
Apr 1, 1979 - Sep 29, 1992
NIH/NCRR
COURSE OF DYSKINESIA
Role: Co-Principal Investigator
Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
Newest
|
Oldest
|
Most Cited
|
Most Discussed
|
Timeline
|
Field Summary
|
Plain Text
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Kleinman RA,
Weiss RD
. Benzodiazepine-Involved Overdose Deaths in the USA: 2000-2019. J Gen Intern Med. 2022 Apr 12.
PMID:
35415793
.
Citations:
Fields:
Int
Internal Medicine
Weiner SG
, Hendricks MA, El Ibrahimi S, Ritter GA, Hallvik SE, Hildebran C,
Weiss RD
,
Boyer EW
, Flores DP, Nelson LS, Kreiner PW, Fischer MA. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone. PLoS One. 2022; 17(4):e0266561.
PMID:
35381052
.
Citations:
Fields:
Med
Medicine (General)
Sci
Science
Translation:
Humans
Connery HS
,
Weiss RD
,
Griffin ML
, Trinh CD, Kim J, Rockett IRH,
McHugh RK
. Suicidal motivations among opioid overdose survivors: Replication and extension. Drug Alcohol Depend. 2022 Jun 01; 235:109437.
PMID:
35427980
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Karnik NS, Marsden J, McCluskey C, Boley RA, Bradley KA, Campbell CI, Curtis ME, Fiellin D, Ghitza U, Hefner K, Hser YI,
McHugh RK
, McPherson SM, Mooney LJ, Moran LM, Murphy SM, Schwartz RP, Shmueli-Blumberg D, Shulman M, Stephens KA, Watkins KE,
Weiss RD
, Wu LT. The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction. 2022 Mar 16.
PMID:
35293064
.
Citations:
Fields:
Sub
Substance-Related Disorders
McHugh RK
, Chase A, Trinh CD,
Weiss RD
. Are Pain and Negative Affect Coping Distinct Motives for Opioid Misuse? Subst Use Misuse. 2022; 57(6):848-852.
PMID:
35258408
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Copersino ML
, Slayter E,
McHugh RK
,
Shedlack KJ
,
Lukas SE
,
Weiss RD
. Clinical utility of a hybrid secondary and relapse prevention program in adults with mild intellectual disability or borderline intellectual functioning in community residential and day habilitation settings. Disabil Health J. 2022 Feb 26; 101293.
PMID:
35337784
.
Citations:
Fields:
Hea
Health Services
Phy
Physical and Rehabilitation Me
Pub
Public Health
Weiner SG
, El Ibrahimi S, Hendricks MA, Hallvik SE, Hildebran C, Fischer MA,
Weiss RD
,
Boyer EW
, Kreiner PW, Wright DA, Flores DP, Ritter GA. Factors Associated With Opioid Overdose After an Initial Opioid Prescription. JAMA Netw Open. 2022 01 04; 5(1):e2145691.
PMID:
35089351
.
Citations:
1
Fields:
Med
Medicine (General)
Translation:
Humans
McHugh RK
, Hilton BT, Chase AM,
Griffin ML
,
Weiss RD
. Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine? Drug Alcohol Depend. 2021 11 01; 228:109084.
PMID:
34607194
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Sugarman DE
,
Busch AB
,
McHugh RK
,
Bogunovic OJ
, Trinh CD,
Weiss RD
,
Greenfield SF
. Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic. Am J Addict. 2021 09; 30(5):445-452.
PMID:
34405475
.
Citations:
2
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
PH
Public Health
Strain EC, Kampman KM,
Weiss RD
. Moving Beyond Medications That Act at the µ Receptor in the Treatment of Opioid Use Disorder. JAMA Psychiatry. 2021 07 01; 78(7):701-702.
PMID:
33851964
.
Citations:
Fields:
Psy
Psychiatry
Psy
Psychology
Translation:
Humans
Hilton BT,
Yusufov M
, Rosellini AJ, Taghian NR,
Weiss RD
,
Griffin ML
,
McHugh RK
. Psychometric properties of the Anxiety Sensitivity Index-3 in adults with substance use disorders. J Subst Abuse Treat. 2022 01; 132:108507.
PMID:
34214925
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Suzuki J
,
Weiss RD
. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? J Addict Med. 2021 04 01; 15(2):91-92.
PMID:
32909980
.
Citations:
1
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Animals
Shulman M,
Weiss R
, Rotrosen J, Novo P, Costello E, Nunes EV. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)". Addict Sci Clin Pract. 2021 03 06; 16(1):15.
PMID:
33676577
.
Citations:
3
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Suzuki J
,
Johnson JA
,
Montgomery MW
, Hayden MC, Price CN,
Solomon DA
, Liebschutz JM,
Schnipper JL
,
Weiss RD
. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. J Addict Med. 2020 12; 14(6):518-519.
PMID:
32187110
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Kneeland ET, Peckham AD,
McHugh RK
,
Weiss RD
, Beard C, Björgvinsson T. Tobacco Use Predicts Treatment Dropout and Outcome in an Acute, Transdiagnostic Psychiatric Treatment Setting. Behav Ther. 2021 07; 52(4):897-906.
PMID:
34134829
.
Citations:
Fields:
Beh
Behavioral Sciences
The
Therapeutics
Translation:
Humans
Becker WC, Krebs EE, Edmond SN, Lin LA, Sullivan MD,
Weiss RD
, Gordon AJ. A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. J Gen Intern Med. 2020 12; 35(Suppl 3):978-982.
PMID:
33145681
.
Citations:
1
Fields:
Int
Internal Medicine
Translation:
Humans
Taghian NR,
McHugh RK
,
Griffin ML
, Chase AR,
Greenfield SF
,
Weiss RD
. Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders. Subst Use Misuse. 2021; 56(1):87-92.
PMID:
33131372
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
McHugh RK
, Trinh CD,
Griffin ML
,
Weiss RD
. Validation of the craving scale in a large sample of adults with substance use disorders. Addict Behav. 2021 02; 113:106651.
PMID:
33086155
.
Citations:
Fields:
Beh
Behavioral Sciences
Sub
Substance-Related Disorders
Translation:
Humans
Lipsitz SR
,
Fitzmaurice GM
,
Weiss RD
. Using Multiple Imputation with GEE with Non-monotone Missing Longitudinal Binary Outcomes. Psychometrika. 2020 12; 85(4):890-904.
PMID:
33006740
.
Citations:
Fields:
Beh
Behavioral Sciences
Translation:
Humans
Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D,
Weiss RD
, Samet JH, Larochelle MR. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis. JAMA Netw Open. 2020 10 01; 3(10):e2016228.
PMID:
33052402
.
Citations:
16
Fields:
Med
Medicine (General)
Translation:
Humans
Weiss RD
. Establishing the First Annual Meetings of the American Academy of Addiction Psychiatry. Am J Addict. 2020 09; 29(5):373-374.
PMID:
32902043
.
Citations:
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
McHugh RK
, Geyer RB, Chase AR,
Griffin ML
,
Bogunovic O
,
Weiss RD
. Sex differences in benzodiazepine misuse among adults with substance use disorders. Addict Behav. 2021 01; 112:106608.
PMID:
32861991
.
Citations:
5
Fields:
Beh
Behavioral Sciences
Sub
Substance-Related Disorders
Translation:
Humans
Suzuki J
,
Johnson JA
,
Montgomery MW
, Hayden MC, Price CN,
Solomon DA
, Liebschutz JM,
Schnipper JL
,
Weiss RD
. Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. J Addict Med. 2020 Jul/Aug; 14(4):282-286.
PMID:
31634202
.
Citations:
7
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
McHugh RK
, Votaw VR, Taghian NR,
Griffin ML
,
Weiss RD
. Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use. J Subst Abuse Treat. 2020 10; 117:108061.
PMID:
32811622
.
Citations:
2
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
King CD, Hilton BT,
Greenfield SF
,
McHugh RK
,
Griffin ML
,
Weiss RD
,
Ressler KJ
. Anxiety sensitivity and grit as mediators between childhood abuse and relapse risk for substance use. Child Abuse Negl. 2020 09; 107:104568.
PMID:
32559552
.
Citations:
Fields:
Ped
Pediatrics
Translation:
Humans
Votaw VR, Witkiewitz K, Vowles KE,
Weiss RD
,
Griffin ML
,
McHugh RK
. Pain interference and catastrophizing are not associated with polysubstance use among treatment-seeking patients with substance use disorders and chronic pain. Am J Drug Alcohol Abuse. 2020 09 02; 46(5):604-612.
PMID:
32529847
.
Citations:
1
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Peckham AD,
Griffin ML
,
McHugh RK
,
Weiss RD
. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug Alcohol Depend. 2020 Jun 12; 213:108122.
PMID:
32563846
.
Citations:
4
Fields:
Sub
Substance-Related Disorders
Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, McRae-Clark AL, Montoya I, Peters EN, Ramey T, Turk DC, Vandrey R,
Weiss RD
, Strain EC. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993.
PMID:
32360455
.
Citations:
13
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
McHugh RK
, Janes AC,
Griffin ML
, Taghian N,
Greenfield SF
,
Weiss RD
. Clinical Correlates of Smoking Status in Men and Women with Opioid Use Disorder. Subst Use Misuse. 2020; 55(7):1054-1058.
PMID:
32037945
.
Citations:
1
Fields:
Sub
Substance-Related Disorders
Translation:
Humans
Connery HS
,
Weiss RD
. Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know? Am J Psychiatry. 2020 02 01; 177(2):104-106.
PMID:
32008394
.
Citations:
2
Fields:
Psy
Psychiatry
Translation:
Humans